Wendy Hill
ENTREPRENEUR IN RESIDENCE, MaRS VENTURE GROUP
MaRS, TorontoWendy Hill has over 25 years experience in drug development in a variety of therapeutic areas including cancer, inflammation, infection and cardiovascular diseases. She has held senior management positions in established pharmaceutical and biotech companies, including director of research at Knoll Canada Inc., senior director of clinical research at GLYCODesign Inc. and R&D director, inflammation and neurology, Amgen Canada Inc. Over the years, Wendy has been responsible for preclinical proof of concept and clinical development research, regulatory and government affairs efforts, quality assurance, medical information and drug safety, formulation development, the development of strategic marketing plans, and partnering and licensing activities. In the spring of 2004, Wendy established her company Gap Strategies, a consulting business that focuses on strategic planning assistance for Canadian and U.S. early- and later-stage biotech and pharmaceutical companies. Wendy holds a MSc in epidemiology from Queen’s University in Kingston, Ontario.